Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Chronic Venous Insufficiency

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    41 result(s) found for: Chronic Venous Insufficiency. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2006-005721-28 Sponsor Protocol Number: IC4-05682-099 Start Date*: 2007-04-10
    Sponsor Name:Servier s.r.o.
    Full Title: EDET study - Efficacy of Detralex® in Edema Treatment. An open, 6-month, multicentre study.
    Medical condition: Treatment of Chronic Venous Disorder symptoms
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047220 Venous (peripheral) insufficiency, unspecified LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2005-003771-20 Sponsor Protocol Number: BI 1138.10 Start Date*: 2006-02-09
    Sponsor Name:Boehringer Ingelheim GmbH
    Full Title: A 12-week, double-blind, randomised, placebo-controlled, multicentre trial to evaluate efficacy and tolerability of Antistax® film-coated tablets, 360 mg/day orally, in male and female patients suf...
    Medical condition: chronic venous insufficiency
    Disease: Version SOC Term Classification Code Term Level
    8.1 10047220 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) AT (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2008-003932-40 Sponsor Protocol Number: 1138.11 Start Date*: 2009-03-26
    Sponsor Name:Boerhinger Ingelheim Pharma GmbH & Co.KG
    Full Title: A 12-week, double-blind, randomised, placebo-controlled, multicentre trial to evaluate efficacy and tolerability of Antistax® film-coated tablets, 720mg/day orally, in male and female patients suff...
    Medical condition: chronic venous insufficiency
    Disease: Version SOC Term Classification Code Term Level
    9.1 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-021270-11 Sponsor Protocol Number: CL2-05682-102 Start Date*: 2010-09-30
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: Impact of Daflon 500 mg on the progression of chronic venous disease and symptoms in patients operated on for varicose veins with conservation of the great saphenous vein. A multicentre, double bl...
    Medical condition: Patients suffering from chronic venous disease and for whom ASVAL (Ambulatory Selective Varicose veins Ablation Local anesthesia) surgery is indicated.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2009-013391-44 Sponsor Protocol Number: EDX09/01 Start Date*: 2010-02-05
    Sponsor Name:OM PHARMA SA
    Full Title: Multicentre, double blind, placebo-controlled, randomised clinical study to assess the efficacy and safety of Doxium® 500 three times daily in patients suffering from chronic venous insufficiency (...
    Medical condition: Chronic Venous Insufficiency (CVI) CEAP Class C3 or C4
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) PT (Completed) PL (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2016-000783-42 Sponsor Protocol Number: SDX-PL/001/2016 Start Date*: 2016-09-19
    Sponsor Name:Alfa Wassermann Polska Sp. z o.o.
    Full Title: A phase 3, prospective, open, pilot, monocentric study to evaluate the effect of sulodexide administered at registered dose on morphology and functional properties of the venous endothelium in pati...
    Medical condition: chronic venous insufficiency
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004866 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-001947-23 Sponsor Protocol Number: PEL01CVH Start Date*: 2007-11-28
    Sponsor Name:HELP Pharmaceuticals S.A.
    Full Title: A multicenter, randomized, parallel patients’ group, comparative clinical trial for the assessement of efficacy and safety of Pelethrocin®/HELP 500 mg (generic diosmin & hesperidin MPFF) versus Daf...
    Medical condition: Chronic Venous Insufficiency
    Disease: Version SOC Term Classification Code Term Level
    9.1 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-000652-14 Sponsor Protocol Number: L00085 CP 403 Start Date*: 2007-09-28
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: Etude en double aveugle versus placebo de l’efficacité et de la tolérance de Cirkan® sur la symptomatologie fonctionnelle veineuse éprouvée (C0s à C3s) par les patientes obèses
    Medical condition: femmes âgées de plus de 18 ans dont le consentement éclairé écrit a été obtenu, affiliées à un régime de sécurité sociale française, non susceptibles d’être enceinte ou de l’être au cours de l’étud...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10057320 Venous insufficiency PT
    9.1 10029883 Obesity PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2012-003559-13 Sponsor Protocol Number: CL3-05682-105 Start Date*: 2013-05-20
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomat...
    Medical condition: Patients suffering from symptomatic Chronic Venous Disease (CVD).
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004866 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SI (Completed) CZ (Completed) ES (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2021-002311-64 Sponsor Protocol Number: SuloPrima Start Date*: 2021-10-01
    Sponsor Name:ALFASIGMA CZECH s.r.o.
    Full Title: Efficacy and safety of sulodexide in the treatment of chronic primary venous disease of the lower extremities: randomized double-blind placebo-controlled clinical trial
    Medical condition: Chronic primary venous disease of the lower limbs
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004866 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2017-003633-28 Sponsor Protocol Number: CL3-05682-109 Start Date*: 2018-05-02
    Sponsor Name:Institut de Recherches Internationales SERVIER (I.R.I.S.)
    Full Title: Clinical non-inferiority study between Micronized purified flavonoid fraction 1000 mg, one chewable tablet per day and Micronized Purified Flavonoid Fraction 500 mg, 2 tablets daily after eight ...
    Medical condition: symptomatic Chronic Venous Disease (CVD).
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004866 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) AT (Completed) RO (Completed)
    Trial results: View results
    EudraCT Number: 2004-002122-22 Sponsor Protocol Number: 02-VLU-003 Start Date*: 2005-06-24
    Sponsor Name:Intercytex Limited
    Full Title: A prospective, multi-centre, double blind, randomized, placebo controlled trial to evaluate the safety and efficacy of ICXP007 in a phase III trial with four-layer therapeutic compression, for trea...
    Medical condition: Venous Insufficiency Leg Ulcers
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002858-37 Sponsor Protocol Number: DOBESILATO500/2 Start Date*: 2008-01-23
    Sponsor Name:FUNDACIÓN IBEROAMERICANA ITACA
    Full Title: ENSAYO CLÍNICO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, PARALELO, COMPARADO CON PLACEBO PARA VALORAR LA EFICACIA DEL DOBESILATO CÁLCICO EN EL TRATAMIENTO DE LAS ÚLCERAS SECUNDARIAS A INSUFICIENCIA...
    Medical condition: Úlceras cutáneas secundarias a insuficiencia venosa crónica (Skin ulcers secondaries to chronic venous insufficiency)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-001855-37 Sponsor Protocol Number: OCT02-2006 Start Date*: 2007-05-14
    Sponsor Name:Schülke & Mayr GmbH
    Full Title: Effect of an octenidine-based topical antimicrobial agent (Octenisept) on wound healing of chronic venous leg ulcers: a prospective, twelve-week comparison versus local treatment with Ringer soluti...
    Medical condition: Chronic venous leg ulcers In Germany, approximately three million people suffer from chronic leg ulcers of various origins. These ulcers are often very painful and extremely cost-intensive disease...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10066677 Chronic leg ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) FR (Completed) HU (Prematurely Ended) GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-014681-25 Sponsor Protocol Number: DC 0982 GE 203 1B Start Date*: 2009-10-21
    Sponsor Name:PIERRE FABRE MEDICAMENT-IRPF-IDPF
    Full Title: Pharmacodynamic and clinical assessment of DC 982 GE (2,4 or 6 capsules per day) in patients with chronic venous disorders : randomised, placebo-controlled, dose effect, double blind, parallel gro...
    Medical condition: Treatment of venous lymphatic insufficiency symptoms related to chronic venous disorders.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed) EE (Completed) LT (Completed)
    Trial results: View results
    EudraCT Number: 2013-003104-39 Sponsor Protocol Number: SIS-05-2013 Start Date*: 2013-12-18
    Sponsor Name:Fakultní nemocnice Ostrava,Czech republic
    Full Title: Randomised Clinical Study of Safety of Efficacy of Extracelular Matrix and Autologous Platelet Rich Plasma Concentrate for Wound Healing (Leg Ulcers Biodesign Wound Healing – LEGEND(A) Study) In...
    Medical condition: Chronical ischemic and venous ulcers
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-007748-85 Sponsor Protocol Number: DT-DP-D02 Start Date*: 2008-06-26
    Sponsor Name:DermaTools Biotech GmbH
    Full Title: A Prospective, Randomized, Open Label, Add-On, Parallel Arm, In-Patient Comparison Phase II Study to Evaluate the Safety and Efficacy of Diperoxochloric Acid (DermaPro®) in Wounds with Impaired Hea...
    Medical condition: Wounds with Impaired Healing
    Disease: Version SOC Term Classification Code Term Level
    9.1 10048037 Wound healing disturbance of LLT
    9.1 10048036 Wound healing delayed LLT
    9.1 10012664 Diabetic foot ulcer LLT
    9.1 10047246 Venous stasis ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-005612-40 Sponsor Protocol Number: DAM/001/08 Start Date*: 2008-11-27
    Sponsor Name:FARMACEUTICI DAMOR
    Full Title: Open-label, controlled, randomised, multicentre, parallel group clinical trial of efficacy and tolerability of heparan sulfate slow-release 120 mg tablets and defibrotide 400 mg capsules in the tre...
    Medical condition: Patients with chronic venous insufficiency
    Disease: Version SOC Term Classification Code Term Level
    9.1 10013283 Disorder vascular peripheral LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-001551-38 Sponsor Protocol Number: ghnhsft Start Date*: 2005-09-29
    Sponsor Name:Gloucestershire Hospitals NHS Foundation Trust
    Full Title: A study to research if foam sclerotherapy of saphenous trunks can speed up the healing of chronic venous leg ulcers
    Medical condition: We will include patients with insufficiency of the long and/or short saphenous vein as underlying cause of their venous leg ulcer. These patients may or may not have visible varicose veins of the l...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-004804-23 Sponsor Protocol Number: KCT13/2017–FLEBAVEN/SI Start Date*: 2018-06-15
    Sponsor Name:Krka, d.d., Novo mesto
    Full Title: The efficacy and safety of a single dose Flebavena® (Diosmin) of 1000 mg per day in patients with chronic venous disease (LIGHTEN-UP)
    Medical condition: Patients diagnosed with primary chronic vein disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004866 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SI (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 02:20:17 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA